Rethinkinghealthcare

Over 300 products

Over 35 subsidiaries

40 countries

2,000 medical representatives

4,000 professionals

Exeltis, the branded pharmaceutical division of Chemo Group, is a global organization with an excellent capacity for discovering, developing, producing and marketing medicines and health products.

A Global PharmaGroup

The numbers speak for us:

Many years ago,we started thinkingabout how healthcare should be.We’ve got it.#RethinkingHealthcare

Identity

A matter of balanceExeltis is a celebration of excellence, innovation and diversity.

Our symbol appeals to the deepest core of our essence. As a tribute to perfection and excellence, we have drawn inspiration from the golden ratio.

A completely proportionate identity that provides perfect balance and a distinctive personality.

The insight:Rethinking Healthcare• An enterprising, innovative outlook that fuses

knowledge and experience.

• A non-conformist, non-traditional organization that is constantly evolving.

• A passionate, creative, flexible team that is dedicated to improving people’s health.

Re-thinking implies Innovation.

Our driving forceOur constant passion to find and attain excellence allows us to develop innovative treatments on the five continents, as well as to meet unmet medical needs of people, families and health professionals.

An opportunity to make a difference in the lives of millions of people today and in the future.

Business ScopeBusiness Scope

R&D – Research & DevelopmentExeltis’ research is carried out in synergy with the research efforts of the CHEMO Group, the resources of affiliates around the world and the corporate research center, Ladee Pharma Research Institute (LPRI), specialized in researching and developing new products from phase I to approval.

This active cooperation and alignment enableExeltis to advance and generate an extensive product portfolio.

Our healthcare areasWe create solutions for Women's Health and other priorities such as Respiratory, Derma-tology and Endocrinology.

The organization operates a global production network, with centers in Europe, The Americas and Asia.

Our strength and great commitmentTo accompany women in all phases of their lives (contraception, pregnancy,fertility,meno-pause), and to offer them a variety of gynae-cological products adapted to their needs.

Corporate Social ResponsibilityOur social commitment is realized through Fundación Mundo Sano (www.mundosano.org), where we work to reduce the impact of Neglected Tropical Diseases (NTDs) such as Chagas disease or Dengue.

www.exeltis.com